{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:54:34Z","timestamp":1790024074550,"version":"4.0.1"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T00:00:00Z","timestamp":1571270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"NCI Cancer Center Core","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Melanoma brain metastases historically portend a dismal prognosis, but recent advances in immune checkpoint inhibitors (ICIs) have been associated with durable responses in some patients. There are no validated imaging biomarkers associated with outcomes in patients with melanoma brain metastases receiving ICIs. We hypothesized that radiomic analysis of magnetic resonance images (MRIs) could identify higher-order features associated with survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between 2010 and 2019, we retrospectively reviewed patients with melanoma brain metastases who received ICI. After volumes of interest were drawn, several texture and edge descriptors, including first-order, Haralick, Gabor, Sobel, and Laplacian of Gaussian (LoG) features were extracted. Progression was determined using Response Assessment in Neuro-Oncology Brain Metastases. Univariate Cox regression was performed for each radiomic feature with adjustment for multiple comparisons followed by Lasso regression and multivariate analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eighty-eight patients with 196 total brain metastases were identified. Median age was 63.5 years (range, 19\u201391 y). Ninety percent of patients had Eastern Cooperative Oncology Group performance status of 0 or 1 and 35% had elevated lactate dehydrogenase. Sixty-three patients (72%) received ipilimumab, 11 patients (13%) received programmed cell death protein 1 blockade, and 14 patients (16%) received nivolumab plus ipilimumab. Multiple features were associated with increased overall survival (OS), and LoG edge features best explained the variation in outcome (hazard ratio: 0.68, P = 0.001). In multivariate analysis, a similar trend with LoG was seen, but no longer significant with OS. Findings were confirmed in an independent cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Higher-order MRI radiomic features in patients with melanoma brain metastases receiving ICI were associated with a trend toward improved OS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuonc\/noz141","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T15:31:08Z","timestamp":1570807868000},"page":"1578-1586","source":"Crossref","is-referenced-by-count":58,"title":["MRI radiomic features are associated with survival in melanoma brain metastases treated with immune checkpoint inhibitors"],"prefix":"10.1093","volume":"21","author":[{"given":"Ankush","family":"Bhatia","sequence":"first","affiliation":[{"name":"Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell","family":"Birger","sequence":"additional","affiliation":[{"name":"Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harini","family":"Veeraraghavan","sequence":"additional","affiliation":[{"name":"Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyemin","family":"Um","sequence":"additional","affiliation":[{"name":"Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Tixier","sequence":"additional","affiliation":[{"name":"Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Sophia","family":"McKenney","sequence":"additional","affiliation":[{"name":"Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Cugliari","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalise","family":"Caviasco","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Bialczak","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachna","family":"Malani","sequence":"additional","affiliation":[{"name":"Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Flynn","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T Jonathan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca D","family":"Santomasso","sequence":"additional","affiliation":[{"name":"Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander N","family":"Shoushtari","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,17]]},"reference":[{"issue":"8","key":"2020071622430467500_CIT0001","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/neuonc\/now127","article-title":"Updates in the management of brain metastases","volume":"18","author":"Arvold","year":"2016","journal-title":"Neuro Oncol."},{"issue":"8","key":"2020071622430467500_CIT0002","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/cncr.25634","article-title":"Prognostic factors for survival in melanoma patients with brain metastases","volume":"117","author":"Davies","year":"2011","journal-title":"Cancer."},{"issue":"1","key":"2020071622430467500_CIT0003","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3171\/jns.1998.88.1.0011","article-title":"Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma","volume":"88","author":"Sampson","year":"1998","journal-title":"J Neurosurg."},{"issue":"7","key":"2020071622430467500_CIT0004","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1200\/JCO.2004.08.140","article-title":"Determinants of outcome in melanoma patients with cerebral metastases","volume":"22","author":"Fife","year":"2004","journal-title":"J Clin Oncol."},{"issue":"8","key":"2020071622430467500_CIT0005","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/cncr.25631","article-title":"Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma","volume":"117","author":"Eigentler","year":"2011","journal-title":"Cancer."},{"issue":"2","key":"2020071622430467500_CIT0006","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1215\/15228517-2007-058","article-title":"Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features","volume":"10","author":"Raizer","year":"2008","journal-title":"Neuro Oncol."},{"issue":"1","key":"2020071622430467500_CIT0007","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/S1470-2045(17)30693-9","article-title":"Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the response assessment in neuro-oncology brain metastases working group","volume":"19","author":"Camidge","year":"2018","journal-title":"Lancet Oncol."},{"issue":"7","key":"2020071622430467500_CIT0008","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1470-2045(16)30053-5","article-title":"Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial","volume":"17","author":"Goldberg","year":"2016","journal-title":"Lancet Oncol."},{"issue":"5","key":"2020071622430467500_CIT0009","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1470-2045(18)30139-6","article-title":"Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study","volume":"19","author":"Long","year":"2018","journal-title":"Lancet Oncol."},{"issue":"8","key":"2020071622430467500_CIT0010","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa1805453","article-title":"Combined nivolumab and ipilimumab in melanoma metastatic to the brain","volume":"379","author":"Tawbi","year":"2018","journal-title":"N Engl J Med."},{"issue":"9","key":"2020071622430467500_CIT0011","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1158\/2326-6066.CIR-18-0067","article-title":"Improved risk-adjusted survival for melanoma brain metastases in the era of checkpoint blockade immunotherapies: results from a national cohort","volume":"6","author":"Iorgulescu","year":"2018","journal-title":"Cancer Immunol Res."},{"issue":"16","key":"2020071622430467500_CIT0012","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1158\/0008-5472.CAN-15-3476","article-title":"Multiregion whole-exome sequencing uncovers the genetic evolution and mutational heterogeneity of early-stage metastatic melanoma","volume":"76","author":"Harbst","year":"2016","journal-title":"Cancer Res."},{"issue":"10","key":"2020071622430467500_CIT0013","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N Engl J Med."},{"issue":"11","key":"2020071622430467500_CIT0014","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1158\/2159-8290.CD-15-0369","article-title":"Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets","volume":"5","author":"Brastianos","year":"2015","journal-title":"Cancer Discov."},{"issue":"5","key":"2020071622430467500_CIT0015","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1109\/PROC.1979.11328","article-title":"Statistical and structural approaches to texture","volume":"67","author":"Haralick","year":"1979","journal-title":"P IEEE."},{"issue":"6","key":"2020071622430467500_CIT0016","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1109\/TSMC.1973.4309314","article-title":"Textural features for image classification","volume":"3","author":"Haralick","year":"1973","journal-title":"IEEE T Syst Man Cyb."},{"key":"2020071622430467500_CIT0017","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/neuonc\/now212.517","article-title":"Radiogenomics to characterize regional genetic heterogeneity in glioblastoma","volume":"18","author":"Hu","year":"2016","journal-title":"Neuro Oncol."},{"issue":"3","key":"2020071622430467500_CIT0018","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1148\/radiol.2018172300","article-title":"MR imaging of rectal cancer: radiomics analysis to assess treatment response after neoadjuvant therapy","volume":"287","author":"Horvat","year":"2018","journal-title":"Radiology."},{"issue":"6","key":"2020071622430467500_CIT0019","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/neuonc\/now256","article-title":"MRI features predict survival and molecular markers in diffuse lower-grade gliomas","volume":"19","author":"Zhou","year":"2017","journal-title":"Neuro Oncol."},{"issue":"2","key":"2020071622430467500_CIT0020","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/jmri.25156","article-title":"Use of texture analysis based on contrast-enhanced MRI to predict treatment response to chemoradiotherapy in nasopharyngeal carcinoma","volume":"44","author":"Liu","year":"2016","journal-title":"J Magn Reson Imaging."},{"issue":"4","key":"2020071622430467500_CIT0021","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/RLI.0000000000000116","article-title":"Texture analysis as imaging biomarker of tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3-T magnetic resonance","volume":"50","author":"De Cecco","year":"2015","journal-title":"Invest Radiol."},{"issue":"4","key":"2020071622430467500_CIT0022","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/jmri.25057","article-title":"Minkowski functionals: an MRI texture analysis tool for determination of the aggressiveness of breast cancer","volume":"43","author":"Fox","year":"2016","journal-title":"J Magn Reson Imaging."},{"issue":"5","key":"2020071622430467500_CIT0023","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.clinimag.2015.04.003","article-title":"Differentiation of true-progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide by GLCM texture analysis of conventional MRI","volume":"39","author":"Chen","year":"2015","journal-title":"Clin Imaging."},{"issue":"8","key":"2020071622430467500_CIT0024","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/nbm.3132","article-title":"Dynamic contrast-enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer","volume":"27","author":"Teruel","year":"2014","journal-title":"NMR Biomed."},{"issue":"11","key":"2020071622430467500_CIT0025","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1118\/1.4934373","article-title":"Evaluation of tumor-derived MRI-texture features for discrimination of molecular subtypes and prediction of 12-month survival status in glioblastoma","volume":"42","author":"Yang","year":"2015","journal-title":"Med Phys."},{"issue":"11","key":"2020071622430467500_CIT0026","doi-asserted-by":"crossref","first-page":"e0141506","DOI":"10.1371\/journal.pone.0141506","article-title":"Multi-parametric MRI and texture analysis to visualize spatial histologic heterogeneity and tumor extent in glioblastoma","volume":"10","author":"Hu","year":"2015","journal-title":"PLoS One."},{"issue":"14","key":"2020071622430467500_CIT0027","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1088\/0031-9155\/60\/14\/5471","article-title":"A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities","volume":"60","author":"Valli\u00e8res","year":"2015","journal-title":"Phys Med Biol."},{"issue":"10","key":"2020071622430467500_CIT0028","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1007\/s00330-015-3701-8","article-title":"Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores","volume":"25","author":"Wibmer","year":"2015","journal-title":"Eur Radiol."},{"issue":"1","key":"2020071622430467500_CIT0029","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1038\/s41598-018-22980-9","article-title":"Appearance constrained semi-automatic segmentation from DCE-MRI is reproducible and feasible for breast cancer radiomics: a feasibility study","volume":"8","author":"Veeraraghavan","year":"2018","journal-title":"Sci Rep."},{"issue":"7","key":"2020071622430467500_CIT0030","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1007\/s00330-016-4623-9","article-title":"Differentiation of uterine leiomyosarcoma from atypical leiomyoma: diagnostic accuracy of qualitative mr imaging features and feasibility of texture analysis","volume":"27","author":"Lakhman","year":"2017","journal-title":"Eur Radiol."},{"issue":"5","key":"2020071622430467500_CIT0031","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/jmri.24890","article-title":"Breast cancer subtype intertumor heterogeneity: MRI-based features predict results of a genomic assay","volume":"42","author":"Sutton","year":"2015","journal-title":"J Magn Reson Imaging."},{"issue":"15","key":"2020071622430467500_CIT0032","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1016\/S1470-2045(15)00088-1","article-title":"Immunotherapy response assessment in neuro-oncology: a report of the RANO working group","volume":"16","author":"Okada","year":"2015","journal-title":"Lancet Oncol."},{"issue":"6","key":"2020071622430467500_CIT0033","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","article-title":"Response assessment criteria for brain metastases: proposal from the RANO group","volume":"16","author":"Lin","year":"2015","journal-title":"Lancet Oncol."},{"issue":"3","key":"2020071622430467500_CIT0034","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","article-title":"User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability","volume":"31","author":"Yushkevich","year":"2006","journal-title":"Neuroimage."},{"key":"2020071622430467500_CIT0035","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1002\/mp.13046","article-title":"Technical note: extension of CERR for computational radiomics: a comprehensive MATLAB platform for reproducible radiomics research","volume":"45","author":"Apte","year":"2018","journal-title":"Med Phys."},{"issue":"46","key":"2020071622430467500_CIT0036","doi-asserted-by":"crossref","first-page":"E6265","DOI":"10.1073\/pnas.1505935112","article-title":"Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images","volume":"112","author":"Fehr","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"7","key":"2020071622430467500_CIT0037","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1364\/JOSAA.2.001160","article-title":"Uncertainty relation for resolution in space, spatial frequency, and orientation optimized by two-dimensional visual cortical filters","volume":"2","author":"Daugman","year":"1985","journal-title":"J Opt Soc Am A."},{"issue":"1","key":"2020071622430467500_CIT0038","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the Lasso","volume":"58","author":"Tibshirani","year":"1996","journal-title":"J Roy Stat Soc B Met."},{"issue":"6","key":"2020071622430467500_CIT0039","doi-asserted-by":"crossref","first-page":"660","DOI":"10.18632\/oncotarget.26578","article-title":"Preoperative MRI-radiomics features improve prediction of survival in glioblastoma patients over MGMT methylation status alone","volume":"10","author":"Tixier","year":"2019","journal-title":"Oncotarget."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noz141\/30160194\/noz141.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/21\/12\/1578\/32927656\/noz141.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/21\/12\/1578\/32927656\/noz141.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T18:33:03Z","timestamp":1721845983000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/21\/12\/1578\/5588961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,17]]},"references-count":39,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,10,17]]},"published-print":{"date-parts":[[2019,12,17]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noz141","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12]]},"published":{"date-parts":[[2019,10,17]]}}}